Induced pluripotent stem cells: A new era for hepatology

被引：54

作者：

Asgari, Samira ^{[1
,2
]}

Pournasr, Behshad ^{[1
]}

Salekdeh, Ghasem Hosseini ^{[3
,4
]}

Ghodsizadeh, Arefeh ^{[1
,2
]}

Ott, Michael ^{[5
,6
]}

Baharvand, Hossein ^{[1
,7
]}

机构：

[1] ACECR, Royal Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Tehran, Iran

[2] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran

[3] ACECR, Royal Inst Stem Cell Biol & Technol, Dept Mol Syst Biol, Tehran, Iran

[4] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran

[5] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany

[6] Ctr Expt & Clin Infect Res, TWINCORE, Hannover, Germany

[7] Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran

来源：

JOURNAL OF HEPATOLOGY | 2010年 / 53卷 / 04期

关键词：

Induced pluripotent stem (iPS) cells; Hepatology; Transplantation; Gene therapy; Bio-artificial livers; Drug development; HEPATOCYTE-LIKE CELLS; ORTHOTOPIC LIVER-TRANSPLANTATION; HIGHLY EFFICIENT DIFFERENTIATION; DENSITY-LIPOPROTEIN RECEPTOR; VIVO GENE-THERAPY; IPS CELLS; BIOARTIFICIAL LIVER; PHASE-I; DIRECTED DIFFERENTIATION; HEPATIC DIFFERENTIATION;

D O I：

10.1016/j.jhep.2010.05.009

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Stem cell transplantation has been proposed as an attractive alternative approach to restore liver mass and function. Recent progress has been reported on the generation of induced pluripotent stem (iPS) cells from somatic cells. Human-iPS cells can be differentiated towards the hepatic lineage which presents possibilities for improving research on diseases, drug development, tissue engineering, the development of bio-artificial livers, and a foundation for producing autologous cell therapies that would avoid immune rejection and enable correction of gene defects prior to cell transplantation. This focused review will discuss how human iPS cell advances are likely to have an impact on hepatology. (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

引用

页码：738 / 751

页数：14

共 50 条

[41] Stem cells: new tools in gastroenterology and hepatology
Piscaglia, AC
Di Campli, C
Gasbarrini, G
Gasbarrini, A
DIGESTIVE AND LIVER DISEASE, 2003, 35 (07) : 507 - 514
[42] Induced Pluripotent Stem Cells and Motor Neuron Disease: Toward an Era of Individualized Medicine
Cashman, Christopher R.
Ospri, Lorenzo Lazzerini
JOURNAL OF NEUROSCIENCE, 2013, 33 (20): : 8587 - 8589
[43] Induced pluripotent stem cells (iPS cells)
Germain, D.
PATHOLOGIE BIOLOGIE, 2009, 57 (7-8): : 555 - 559
[44] Induced pluripotent stem cells: Will they be safe?
Jalving, Mathilde
Schepers, Hein
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2009, 11 (04) : 383 - 393
[45] Induced Pluripotent Stem Cells at Nanoscale
Zeuschner, Dagmar
Mildner, Karina
Zaehres, Holm
Schoeler, Hans R.
STEM CELLS AND DEVELOPMENT, 2010, 19 (05) : 615 - 620
[46] Chemically induced pluripotent stem cells
Nature Methods, 2013, 10 (9) : 821 - 821
[47] Cryopreservation of Induced Pluripotent Stem Cells
Miyamoto, Yoshitaka
Noguchi, Hirofumi
Yukawa, Hiroshi
Oishi, Koichi
Matsushita, Kenji
Iwata, Hisashi
Hayashi, Shuji
CELL MEDICINE, 2012, 3 (1-3): : 89 - 95
[48] Induced Pluripotent Stem Cells and Their Applications
Sevim, Handan
Gurpinar, Ozer Aylin
MARMARA MEDICAL JOURNAL, 2012, 25 (01): : 5 - 9
[49] Pluripotency of induced pluripotent stem cells
Kang, Lan
Gao, Shaorong
JOURNAL OF ANIMAL SCIENCE AND BIOTECHNOLOGY, 2012, 3
[50] Immunogenicity of Induced Pluripotent Stem Cells
Okita, Keisuke
Nagata, Naoki
Yamanaka, Shinya
CIRCULATION RESEARCH, 2011, 109 (07) : 720 - 721

← 1 2 3 4 5 →